Birgit Funke

Birgit Funke

Auto-generated profile, based on publicly available information

Birgit Funke

Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine, Cambridge, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Genetics in Medicine
Verified
Journal Article
Open access
RWRoddy Walsh
Roddy Walsh
KTKate L. Thomson
Kate L. Thomson
JWJames S. Ware
James S. Ware
BFBirgit H. Funke
Birgit H. Funke
JWJessica Woodley
Jessica Woodley
HWHugh Watkins
Hugh Watkins
The accurate interpretation of variation in Mendelian disease genes has lagged behind data generation as sequencing has become increasingly accessible. Ongoing large sequencing efforts present huge interpretive challenges, but they also provide an invaluable opportunity to characterize the spectrum and importance of rare variation. We analyzed sequence data from 7,855 clinical cardiomyopathy cases and 60,706 Exome Aggregation Consortium (ExAC) reference samples to obtain a better understanding of genetic variation in a representative autosomal dominant disorder. We found that in some genes previously reported as important causes of a given cardiomyopathy, rare variation is not clinically informative because there is an unacceptably high likelihood of false-positive interpretation. By contrast, in other genes, we find that diagnostic laboratories may be overly conservative when assessing variant pathogenicity. We outline improved analytical approaches that evaluate which genes and variant classes are interpretable and propose that these will increase the clinical utility of testing across a range of Mendelian diseases.Genet Med 19 2, 192-203.

1 March 2018 in Genetics in Medicine
Verified
Journal Article
Open access
MKMelissa A. Kelly
Melissa A. Kelly
CCColleen Caleshu
Colleen Caleshu
AMAna Morales
Ana Morales
JBJillian Buchan
Jillian Buchan
ZWZena Wolf
Zena Wolf
BFBirgit Funke
Birgit Funke
Integrating genomic sequencing in clinical care requires standardization of variant interpretation practices. The Clinical Genome Resource has established expert panels to adapt the American College of Medical Genetics and Genomics/Association for Molecular Pathology classification framework for specific genes and diseases. The Cardiomyopathy Expert Panel selected MYH7, a key contributor to inherited cardiomyopathies, as a pilot gene to develop a broadly applicable approach. Expert revisions were tested with 60 variants using a structured double review by pairs of clinical and diagnostic laboratory experts. Final consensus rules were established via iterative discussions. Adjustments represented disease-/gene-informed specifications (12) or strength adjustments of existing rules (5). Nine rules were deemed not applicable. Key specifications included quantitative frameworks for minor allele frequency thresholds, the use of segregation data, and a semiquantitative approach to counting multiple independent variant occurrences where fully controlled case-control studies are lacking. Initial inter-expert classification concordance was 93%. Internal data from participating diagnostic laboratories changed the classification of 20% of the variants (n = 12), highlighting the critical importance of data sharing. These adapted rules provide increased specificity for use in MYH7-associated disorders in combination with expert review and clinical judgment and serve as a stepping stone for genes and disorders with similar genetic and clinical characteristics.

16 November 2019 in Genetics in Medicine
Verified
Journal Article
Open access
PDF file
LBLora J. H. Bean
Lora J. H. Bean
BFBirgit Funke
Birgit Funke
CCColleen M. Carlston
Colleen M. Carlston
JGJennifer L. Gannon
Jennifer L. Gannon
SKSibel Kantarci
Sibel Kantarci
PBPinar Bayrak-Toydemir
Pinar Bayrak-Toydemir
Gene sequencing panels are a powerful diagnostic tool for many clinical presentations associated with genetic disorders. Advances in DNA sequencing technology have made gene panels more economical, flexible, and efficient. Because the genes included on gene panels vary widely between laboratories in gene content (e.g., number, reason for inclusion, evidence level for gene–disease association) and technical completeness (e.g., depth of coverage), standards that address technical and clinical aspects of gene panels are needed. This document serves as a technical standard for laboratories designing, offering, and reporting gene panel testing. Although these principles can apply to multiple indications for genetic testing, the primary focus is on diagnostic gene panels (as opposed to carrier screening or predictive testing) with emphasis on technical considerations for the specific genes being tested. This technical standard specifically addresses the impact of gene panel content on clinical sensitivity, specificity, and validity—in the context of gene evidence for contribution to and strength of evidence for gene–disease association—as well as technical considerations such as sequencing limitations, presence of pseudogenes/gene families, mosaicism, transcript choice, detection of copy-number variants, reporting, and disclosure of assay limitations.

1 June 2016 in Genetics in Medicine
Verified
Journal Article
Closed access
ATAhmad N. Abou Tayoun
Ahmad N. Abou Tayoun
STSaeed H. Al Turki
Saeed H. Al Turki
AOAndrea M. Oza
Andrea M. Oza
MBMark J. Bowser
Mark J. Bowser
AHAmy L. Hernandez
Amy L. Hernandez
SASami Amr
Sami Amr

1 December 2019 in Genetics in Medicine
Verified
Journal Article
Closed access
OSOzlem Senol-Cosar
Ozlem Senol-Cosar
RSRyan J. Schmidt
Ryan J. Schmidt
EQEmily Qian
Emily Qian
DHDerick Hoskinson
Derick Hoskinson
HMHeather Mason-Suares
Heather Mason-Suares
MLMatthew Lebo
Matthew Lebo

1 May 2019 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
ASAvni Santani
Avni Santani
BSBirgitte B. Simen
Birgitte B. Simen
MBMarian Briggs
Marian Briggs
MLMatthew Lebo
Matthew Lebo
JMJason D. Merker
Jason D. Merker
BFBirgit Funke
Birgit Funke